Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
πΌ
SK
or Search
SIGN UP
SIGN IN
ENTITY
Shionogi & Co (4507 JP)
Watchlist
188
Analysis
Health Care
β’
Japan
Shionogi & Company Ltd., is a pharmaceutical company. The Company develops prescription & over-the-counter drugs and diagnostics.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
β’
Cross Asset Strategy
β’
07 Jul 2022 10:09
β’
Syndicated
CX Daily: China Takes Another Step to Unshackle Interest Rates
Caixin Explains: China takes another step to unshackle interest rates. Uproar over a baby taken during the one-child policy days
Caixin Global
Follow
381 Views
Share
bullish
β’
Thematic (Sector/Industry)
β’
30 May 2022 09:46
Smartkarma Originals
APAC Healthcare β Good Bet on Re-Opening; Continued Strong Recovery in Top Picks
Amid the declining new COVID infections and economy re-opening, top picks in APAC healthcare sector are poised to benefit. Their recent quarterly...
Tina Banerjee
Follow
556 Views
Share
bearish
β’
Thematic (Sector/Industry)
β’
04 Feb 2021 05:25
π―π΅ JAPAN β’ Results & Revisions ββββββββββββββββββββββββββββββ02/βββββββββββββββ03 Hirose, Eisai..
Of Wednesday's 100 results announcements, 78% scored positively for earnings momentum despite trailing revenues falling by 5.7% on average and a...
Campbell Gunn
Follow
387 Views
Share
bullish
β’
Thematic (Sector/Industry)
β’
02 Feb 2021 06:39
π―π΅ JAPAN β’ Results & Revisions ββββββββββββββββββββββββββββββ02/βββββββββββββ01 - Rohm, Shionogi..
Of Monday's 76 results announcements, 79% scored positively for earnings momentum despite trailing revenues falling by 5.2% on average and a 2.6...
Campbell Gunn
Follow
362 Views
Share
bearish
β’
Thematic (Sector/Industry)
β’
27 Apr 2020 04:41
π―π΅ JAPAN MARKET (& COVID-19) UPDATE 26th April - Thin End of the Wedge
THE WEDGE - Both Japanese equities and the $/Β₯ exchange rate have traded in a narrow range over the last two weeks. Undeterred, the Bank of Japan...
Campbell Gunn
Follow
418 Views
Share
First
Previous
9
10
11
12
13
14
15
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright Β© 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x